⌘K

Login Start Free

Home/Filings/4/0001780854-25-000003

4//SEC Filing

BENZENO SHARON 4

Accession 0001780854-25-000003

CIK 0001478320other

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 8:00 PM ET

Size

17.2 KB

Accession

0001780854-25-000003

Insider Transaction Report

Form 4

Period: 2025-12-04

Adaptive Biotechnologies CorpADPT

Chief Commercial Ofc Imm Med

Transactions

Exercise/Conversion
Common Stock
2025-12-04$12.14/sh+4,290$52,081→ 301,081 total
Exercise/Conversion
Common Stock
2025-12-04$8.46/sh+4,157$35,168→ 305,238 total
Sale
Common Stock
2025-12-04$16.85/sh−12,604$212,377→ 296,791 total
Exercise/Conversion
Stock Option (right to buy)
2025-12-04−4,290→ 12,871 total
Exercise: $12.14Exp: 2032-03-04→ Common Stock (4,290 underlying)
Exercise/Conversion
Stock Option (right to buy)
2025-12-04−4,157→ 62,360 total
Exercise: $8.46Exp: 2033-03-06→ Common Stock (4,157 underlying)

Footnotes (5)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.
[F2]The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.66 to $16.93, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
[F3]The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
[F4]The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
[F5]The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Adaptive Biotechnologies Corp

CIK 0001478320

Entity typeother

Related Parties

1

filerCIK 0001780854

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 8:00 PM ET
Size: 17.2 KB

View on SEC.gov